Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial
Joseph F. Merola,
Cynthia E. Kartman,
Peter Fischer,
Philip Mease,
Alan Kivitz,
Naveed Sattar,
Laura C. Coates,
Daniel Aletaha,
Luna Sun,
Yurong Chen,
Ketan Marulkar,
Natalia Bello,
Anabela Cardoso,
Mark C. Genovese,
Alexis Ogdie
Wiley ·
2026-11-11
· DOI 10.1002/art.70375
⬢ Цитируемость: 0Crossref
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Joseph F. Merola, Cynthia E. Kartman, Peter Fischer, Philip Mease, Alan Kivitz, Naveed Sattar et al. Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial. // Arthritis and Rheumatology. – 2026. – DOI: 10.1002/art.70375. – URL: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70375?af=R
Joseph F. Merola, Cynthia E. Kartman, Peter Fischer, Philip Mease, Alan Kivitz, Naveed Sattar, Laura C. Coates, Daniel Aletaha, Luna Sun, Yurong Chen, Ketan Marulkar, Natalia Bello, Anabela Cardoso, Mark C. Genovese, & Alexis Ogdie (2026). Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial. Arthritis and Rheumatology. https://doi.org/10.1002/art.70375
Joseph F. Merola, et al. “Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial.” Arthritis and Rheumatology, 2026. doi:10.1002/art.70375.
@article{Merola2026,
title = {Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial},
author = {Merola, Joseph F. and Kartman, Cynthia E. and Fischer, Peter and Mease, Philip and Kivitz, Alan and Sattar, Naveed and Coates, Laura C. and Aletaha, Daniel and Sun, Luna and Chen, Yurong and Marulkar, Ketan and Bello, Natalia and Cardoso, Anabela and Genovese, Mark C. and Ogdie, Alexis},
journal = {Arthritis and Rheumatology},
year = {2026},
doi = {10.1002/art.70375},
url = {https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70375?af=R}
}